Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108658784A reveals a novel synthesis route for glaucoma drug intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107586268B reveals a high-yield route for Erexib intermediates using condensing agents, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN109734762B details a novel one-pot method for 16-beta-methyl steroids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Grignard-based route for steroid intermediate offers high yield and mild conditions. Scalable for pharma supply chains ensuring cost reduction and continuity.
Novel 4-step route for Sofosbuvir key intermediate. Avoids hazardous reagents. Reliable supplier for high-purity pharmaceutical intermediates.
Novel synthesis of Abiraterone Acetate via CN107176965A patent. Cost-effective route using pregnadienolone acetate for reliable pharmaceutical intermediate supply chain.
Patent CN104263803A details high-purity S-2-tetrahydronaphthalene amine synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel low-temperature method for delta 16 steroid. High yield, no heavy metals. Reliable supply for adrenal hormone manufacturing.
Patent CN104263799A enables high-purity S-2-tetrahydronaphthylamine via dynamic kinetic resolution. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN101613666B details a novel Bacillus sp. ECU0015 strain for high-purity chiral diol production, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN111675650A details a green photo-induced synthesis for aromatic vinyl bromides. Delivers cost reduction in pharmaceutical intermediate manufacturing with high purity.
Novel TEMPO-mediated route for Vitamin D3 intermediate. Cost-effective, eco-friendly manufacturing process ensuring high purity and supply reliability.
Novel boron-catalyzed method for meta-cyano pyridines. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN109809977A reveals a novel synthesis route offering high purity and substantial cost reduction for pharmaceutical intermediates manufacturing supply chains.
Patent CN103562196A reveals a novel reductive amination route for Dronedarone intermediates, offering high purity and scalable API manufacturing solutions.
Patent CN101709323B reveals a novel biocatalytic coupling method for R-mandelic acid production, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel metal-free cycloaddition method for high-purity triazole intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN104725301A offers a cost-effective route for Perampanel intermediates. Enhances supply chain stability and reduces manufacturing complexity significantly.
Patent CN103343155B offers high-yield fermentation for steroid intermediates, reducing costs and improving supply chain reliability for pharmaceutical manufacturing.
Patent CN1169418A details a novel Lewis acid-catalyzed condensation for polyene esters, offering superior gamma-selectivity and cost reduction in carotenoid manufacturing compared to Wittig reactions.